Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PD-1 Antibody in Addition to Bronchial Arterial Chemoembolization in Patients With Non-Small-Cell Lung Cancer: A Randomised Controlled Trial

NCT05605613 is registered in ClinicalTrials.gov with Xuhua Duan as lead sponsor.

NCT NCT05605613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05605613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PD-1 Antibody in Addition to Bronchial Arterial Chemoembolization in Patients With Non-Small-Cell Lung Cancer: A Randomised Controlled Trial
Lead sponsor
Xuhua Duan
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 29, 2022
Completion date
December 1, 2025
Enrollment
150 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc